Literature DB >> 11352577

The terminal inverted repeats of IS911: requirements for synaptic complex assembly and activity.

C Normand1, G Duval-Valentin, L Haren, M Chandler.   

Abstract

The bacterial insertion sequence IS911 transposes via a covalently closed circular intermediate. Circle formation involves transposase-mediated pairing of both insertion sequence ends. While full-length transposase, OrfAB, binds poorly in vitro to IS911 DNA fragments carrying a copy of the IS911 end, truncated protein derivatives carrying the first 135 (OrfAB[1-135]) or 149 (OrfAB[1-149]) amino acid residues bind efficiently. They generate a paired-end complex containing two such fragments which resembles that expected for the first synaptic complex. Shorter protein derivatives lacking a region involved in multimerisation do not form these complexes but modify the binding of OrfAB[1-135] and OrfAB[1-149]. DNaseI footprinting demonstrated that OrfAB[1-149] protects a sub-terminal (internal) region of the inverted repeats which includes two blocks of sequence (beta and gamma) conserved between the left (IRL) and right (IRR) ends. DNA binding assays in vitro and measurement of recombination activity in vivo of sequential deletion derivatives of the two inverted repeats suggested a model in which the N-terminal region of OrfAB binds the conserved boxes beta and gamma in a sequence-specific manner and anchors the two insertion sequence ends into a paired-end complex. The external region of the inverted repeat is proposed to contact the C-terminal transposase domain carrying the catalytic site. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352577     DOI: 10.1006/jmbi.2001.4641

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Transient promoter formation: a new feedback mechanism for regulation of IS911 transposition.

Authors:  G Duval-Valentin; C Normand; V Khemici; B Marty; M Chandler
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  A target specificity switch in IS911 transposition: the role of the OrfA protein.

Authors:  C Loot; C Turlan; P Rousseau; B Ton-Hoang; M Chandler
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

3.  The helix-turn-helix motif of bacterial insertion sequence IS911 transposase is required for DNA binding.

Authors:  Philippe Rousseau; Erwan Gueguen; Guy Duval-Valentin; Mick Chandler
Journal:  Nucleic Acids Res       Date:  2004-02-23       Impact factor: 16.971

4.  Functional organization of the inverted repeats of IS30.

Authors:  Mónika Szabó; János Kiss; Ferenc Olasz
Journal:  J Bacteriol       Date:  2010-04-23       Impact factor: 3.490

5.  Characterization of the transposase encoded by IS256, the prototype of a major family of bacterial insertion sequence elements.

Authors:  Susanne Hennig; Wilma Ziebuhr
Journal:  J Bacteriol       Date:  2010-06-11       Impact factor: 3.490

6.  Assembly of the mariner Mos1 synaptic complex.

Authors:  Corinne Augé-Gouillou; Benjamin Brillet; Marie-Hélène Hamelin; Yves Bigot
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Bias between the left and right inverted repeats during IS911 targeted insertion.

Authors:  P Rousseau; C Loot; C Turlan; S Nolivos; M Chandler
Journal:  J Bacteriol       Date:  2008-06-27       Impact factor: 3.490

8.  A model for the molecular organisation of the IS911 transpososome.

Authors:  Philippe Rousseau; Catherine Tardin; Nathalie Tolou; Laurence Salomé; Mick Chandler
Journal:  Mob DNA       Date:  2010-06-16

Review 9.  The emerging diversity of transpososome architectures.

Authors:  Fred Dyda; Michael Chandler; Alison Burgess Hickman
Journal:  Q Rev Biophys       Date:  2012-11       Impact factor: 5.318

10.  Cotesia congregata Bracovirus Circles Encoding PTP and Ankyrin Genes Integrate into the DNA of Parasitized Manduca sexta Hemocytes.

Authors:  Germain Chevignon; Georges Periquet; Gabor Gyapay; Nathalie Vega-Czarny; Karine Musset; Jean-Michel Drezen; Elisabeth Huguet
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.